Carl Sailer
Vermögen: 11 019 $ am 30.06.2026
Vermögen: 11 019 $ am 30.06.2026
Carl V.
Sailer currently works at Acurx Pharmaceuticals, Inc., as Independent Director from 2018 and Syneos Health, Inc., as Vice President-Global Client Solutions from 2019.
Mr. Sailer also formerly worked at Emisphere Technologies, Inc., as Vice President-Sales & Marketing from 2012 to 2019, Interpace Biosciences, Inc., as Vice President-Product Commercialization, Akrimax Pharmaceuticals LLC, as Vice President-Commercial Operations from 2008 to 2010, and New American Therapeutics, Inc., as Vice President-Product Commercialization from 2010 to 2012.
Mr. Sailer received his Masters Business Admin degree from Hofstra University and undergraduate degree from Seton Hall University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 7’109 ( 0.45% ) | 11 019 $ | 30.06.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ACURX PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 23.10.2018 |
| SYNEOS HEALTH, INC. | Corporate Officer/Principal | 01.05.2019 |
| Unternehmen | Position | Ende |
|---|---|---|
| EMISPHERE TECHNOLOGIES, INC. | Vertrieb & Marketing | 01.03.2019 |
New American Therapeutics, Inc.
New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapeutic medicines | Corporate Officer/Principal | 01.09.2012 |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures medicines for metabolic syndrome | Corporate Officer/Principal | 01.07.2010 |
| INTERPACE BIOSCIENCES, INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 8 |
|---|---|
Emisphere Technologies, Inc.
Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical and drug delivery company | Health Technology |
Interpace Biosciences, Inc.
Interpace Biosciences, Inc. Medical SpecialtiesHealth Technology Provides commercialization services to biopharmaceutical companies | Health Technology |
Akrimax Pharmaceuticals LLC
Akrimax Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures medicines for metabolic syndrome | Health Technology |
Hofstra University
Hofstra University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seton Hall University
Seton Hall University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New American Therapeutics, Inc.
New American Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapeutic medicines | Health Technology |
Syneos Health, Inc.
Syneos Health, Inc. BiotechnologyHealth Technology Provides outsourced clinical development and commercialization services to biopharmaceutical companies | Health Technology |
Acurx Pharmaceuticals, Inc.
Acurx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company which develops antibiotics for infections caused by bacteria | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen